Research Highlight

In Situ Tumor-Infiltrating Lymphocyte Therapy by Local Delivery of an mRNA Encoding Membrane-Anchored Anti-CD3 Single-Chain Variable Fragment

Prof. Park’s group developed mRNA-LNPs to engineer macrophages and cancer cells in solid tumors for in situ TIL therapy, demonstrating significant antitumor effects. ...read more